Findings

What do systematic reviews say?

4,929 questions · 15,174 findings · 2,372 reviews

Sort:Best matchNewestHighest certainty Download CSV

No studies found 15,174 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (long term)

Clinical severity scales · people who underwent a lower limb revascularisation

The review found no eligible studies for this question.

1 finding from 1 review

Duplex ultrasound for surveillance of lower limb revascularisation 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (long term)

Quality of life scores · people who underwent a lower limb revascularisation

The review found no eligible studies for this question.

1 finding from 1 review

Duplex ultrasound for surveillance of lower limb revascularisation 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (short term)

Adverse events resulting from DUS surveillance · people who underwent a lower limb revascularisation

The review found no eligible studies for this question.

1 finding from 1 review

Duplex ultrasound for surveillance of lower limb revascularisation 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (short term)

Functional walking ability · people who underwent a lower limb revascularisation

The review found no eligible studies for this question.

1 finding from 1 review

Duplex ultrasound for surveillance of lower limb revascularisation 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (short term)

Clinical severity scales · people who underwent a lower limb revascularisation

The review found no eligible studies for this question.

1 finding from 1 review

Duplex ultrasound for surveillance of lower limb revascularisation 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (long term)

Limb salvage · people who underwent a lower limb revascularisation

The review found no eligible studies for this question.

1 finding from 1 review

Duplex ultrasound for surveillance of lower limb revascularisation 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Weekly educational texts messages vs once every other week educational text messages

Flare‐ups or relapse (continuous) · people with inflammatory bowel disease

The review found no eligible studies for this question.

1 finding from 1 review

Patient education interventions for the management of inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Weekly educational texts messages vs once every other week educational text messages

Flare‐ups/relapse (dichotomous; adults) · people with inflammatory bowel disease

The review found no eligible studies for this question.

1 finding from 1 review

Patient education interventions for the management of inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Web‐based patient education vs other delivery of patient education

Flare‐ups or relapse (continuous) · people with inflammatory bowel disease

The review found no eligible studies for this question.

1 finding from 1 review

Patient education interventions for the management of inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Web‐based patient education vs other delivery of patient education

Flare‐ups/relapse (dichotomous; adults) · people with inflammatory bowel disease

The review found no eligible studies for this question.

1 finding from 1 review

Patient education interventions for the management of inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

High‐dose vs standard‐dose strategies

Major neurodevelopmental disability in children aged 18 to 24 months CA · preterm infants at risk for apnea

The review found no eligible studies for this question.

1 finding from 1 review

Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

High‐dose vs standard‐dose strategies

Mortality or major neurodevelopmental disability in children aged 18 to 24 months and 3 to 5 years CA · preterm infants at risk for apnea

The review found no eligible studies for this question.

1 finding from 1 review

Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

High‐dose vs standard‐dose strategies

Side effects (tachycardia, agitation, or feed intolerance) leading to a reduction in dose or withholding of caffeine · preterm infants at risk for apnea

The review found no eligible studies for this question.

1 finding from 1 review

Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

High‐dose vs standard‐dose strategies

Seizures (clinically diagnosed; diagnosed by electroencephalography) · preterm infants at risk for apnea

The review found no eligible studies for this question.

1 finding from 1 review

Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

High‐dose vs standard‐dose strategies

Major neurodevelopmental disability in children aged 18 to 24 months CA · preterm infants with or at risk for apnea of prematurity

The review found no eligible studies for this question.

3 findings from 1 review

Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

High‐dose vs standard‐dose strategies

Major neurodevelopmental disability in children aged 3 to 5 years CA · preterm infants with or at risk for apnea of prematurity

The review found no eligible studies for this question.

2 findings from 1 review

Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

High‐dose vs standard‐dose strategies

Mortality or major neurodevelopmental disability in children aged 18 to 24 months and 3 to 5 years CA · preterm infants with or at risk for apnea of prematurity

The review found no eligible studies for this question.

3 findings from 1 review

Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

High‐dose vs standard‐dose strategies

Length of hospital stay · preterm infants with or at risk for apnea of prematurity

The review found no eligible studies for this question.

2 findings from 1 review

Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

High‐dose vs standard‐dose strategies

Seizures (clinically diagnosed; diagnosed by electroencephalography) · preterm infants with or at risk for apnea of prematurity

The review found no eligible studies for this question.

2 findings from 1 review

Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

High‐dose vs standard‐dose strategies

Side effects (tachycardia, agitation, or feed intolerance) leading to a reduction in dose or withholding of caffeine · preterm infants with or at risk for apnea of prematurity

The review found no eligible studies for this question.

1 finding from 1 review

Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found